| Home | E-Submission | Sitemap | Contact Us |  
J Neurocrit Care > Browse Articles > J Neurocrit Care



Successful treatment of post–COVID-19 acute disseminated encephalomyelitis with urgent immunotherapy and neurointensive management: a case report
Jung Seok Lee, Hong Jun Kim, Joong-Goo Kim
J Neurocrit Care. 2022;15(2):131-135.   Published online December 19, 2022
doi: https://doi.org/10.18700/jnc.220078
                        
Refractory brainstem encephalitis mimicking progressive cerebral infarction: infliximab and methotrexate as a salvage immunotherapy
Sung-Ho Ahn, Jieun Roh, Kyoung-Nam Woo, Hyun-Sung Kim, Min-Gyu Park, Kyung-Pil Park, Seung-Kug Baik, Jin-Hong Shin
J Neurocrit Care. 2021;14(1):46-51.   Published online March 10, 2021
doi: https://doi.org/10.18700/jnc.200025
                        
Favorable clinical course after early-intensive immunotherapy for new-onset refractory status epilepticus
Hyun-Sung Kim, Jiyoung Kim, Bo-Jin Hwang, Kyoung-Nam Woo, Min-Gyu Park, Kyung-Pil Park, Sung-Ho Ahn
J Neurocrit Care. 2020;13(1):65-68.   Published online June 15, 2020
doi: https://doi.org/10.18700/jnc.190115
                        
Consciousness Recovery by Rituximab after Seizure Control in Cryptogenic New-Onset Refractory Status Epilepticus
Tae-Won Yang, Jeong Won Jo, Do-Hyung Kim, Young-Soo Kim, Oh-Young Kwon
J Neurocrit Care. 2018;11(2):137-142.   Published online December 21, 2018
doi: https://doi.org/10.18700/jnc.180066
                        
Corticosteroid Treatment in Autoimmune Encephalitis
Jun-Sang Sunwoo
J Neurocrit Care. 2017;10(2):60-68.   Published online December 27, 2017
doi: https://doi.org/10.18700/jnc.170029
                     Cited By 2
1 |
E-Submission
Endnote Style File
Endnote Style File
Email Alert
Author's Index
SCImago Journal & Country Rank
Supranuclear oculomotor palsy in cerebral venous sinus thrombosis: a case report. J Neurocrit Care. 2021;14:113-116
The author of the accepted manuscript will receive two mugs, printed with an abstract design. We look forward to your continued interest in and support for this journal.
Korean Neurocritical Care Society

First decision

16 Days

Publication after acceptance

42 Days

Submission to publication

80 Days

Acceptance rate

55 %

*Last 12 months

Editorial Office
Department of Neurology and Critical Care, Seoul National University Hospital,
101, Daehak-ro, Jongno-gu, Seoul, 03080 Korea
TEL: +82-2-2072-0743 (10:00 AM ~ 4:00 PM) / +82-2-2072-1810   FAX: +82-2-3672-7553    E-mail: office@e-jnc.org

Copyright© Korean Neurocritical Care Society.                Developed in M2PI